Ombitasvir

CHEMBL3127326 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

894.1 g/mol

LogP

7.9

Phase

4

An antiviral medication used in combination regimens to treat chronic hepatitis C infection by blocking a protein the virus needs to replicate. It is always used with other antiviral drugs to achieve a cure and prevent liver damage.

Moleküler Ağırlık

894,1000 g/mol

LogP

7,90

TPSA

179,00 Å²

Lipinski RO5

Başarısız

Terapötik Alanlar

Hepatitis C

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C

InChI

InChI=1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1

Molecular Formula

C50H67N7O8

HBD / HBA

4 / 9

Döndürülebilir Bağlar

16

Ağır Atomlar

65

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An antiviral medication used in combination regimens to treat chronic hepatitis C infection by blocking a protein the virus needs to replicate. It is always used with other antiviral drugs to achieve a cure and prevent liver damage.

Yes, Ombitasvir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3127326. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 54767916. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Ombitasvir PillFYI'da

Yapı

Hızlı Veriler

Formül: C50H67N7O8

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.